论文部分内容阅读
目的 :观察并分析头孢哌酮钠舒巴坦钠临床应用效果。方法 :随机选取2014年4月-2016年4月间于本院接受治疗的86例感染者为研究对象,依据治疗方法的不同分为2组,对照组采取头孢他啶进行治疗,观察组则采取头孢哌酮舒巴坦钠进行治疗,各纳入43例。结果:观察组临床治疗总有效率约为95.4%,不良反应发生几率约为20.9%,较之对照组均有明显升高(P<0.05)。结论:头孢哌酮舒巴坦钠临床具有较为理想的治疗效果,但该药物较易导致患者出现种种不良反应,故在临床应用此药物的过程中应对患者予以严密监测,以便降低不良反应发生几率,提高临床用药的安全性。
Objective: To observe and analyze the clinical effect of cefoperazone sodium and sulbactam sodium. Methods: Totally 86 infected patients who were treated in our hospital from April 2014 to April 2016 were randomly selected. The patients were divided into two groups according to the treatment methods. The control group was treated with ceftazidime. The observation group was treated with cefotaxime Pipazoles sulbactam sodium for treatment, each included 43 cases. Results: The total effective rate of clinical observation in observation group was 95.4% and the incidence of adverse reactions was about 20.9%, which was significantly higher than that in control group (P <0.05). Conclusion: Cefoperazone sulbactam sodium has an ideal therapeutic effect, but the drug is more likely to cause adverse reactions in patients, so the clinical application of this drug should be closely monitored in patients with the process, in order to reduce the incidence of adverse reactions , Improve the safety of clinical medication.